1. Home
  2. BOLD vs PXLW Comparison

BOLD vs PXLW Comparison

Compare BOLD & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • PXLW
  • Stock Information
  • Founded
  • BOLD 2018
  • PXLW 1997
  • Country
  • BOLD United States
  • PXLW United States
  • Employees
  • BOLD N/A
  • PXLW N/A
  • Industry
  • BOLD
  • PXLW Semiconductors
  • Sector
  • BOLD
  • PXLW Technology
  • Exchange
  • BOLD Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • BOLD 24.4M
  • PXLW 64.2M
  • IPO Year
  • BOLD 2024
  • PXLW 2000
  • Fundamental
  • Price
  • BOLD $1.19
  • PXLW $10.68
  • Analyst Decision
  • BOLD Buy
  • PXLW Strong Buy
  • Analyst Count
  • BOLD 3
  • PXLW 2
  • Target Price
  • BOLD $4.00
  • PXLW $15.00
  • AVG Volume (30 Days)
  • BOLD 105.1K
  • PXLW 104.1K
  • Earning Date
  • BOLD 08-11-2025
  • PXLW 08-06-2025
  • Dividend Yield
  • BOLD N/A
  • PXLW N/A
  • EPS Growth
  • BOLD N/A
  • PXLW N/A
  • EPS
  • BOLD N/A
  • PXLW N/A
  • Revenue
  • BOLD N/A
  • PXLW $34,246,000.00
  • Revenue This Year
  • BOLD N/A
  • PXLW $5.21
  • Revenue Next Year
  • BOLD N/A
  • PXLW $35.68
  • P/E Ratio
  • BOLD N/A
  • PXLW N/A
  • Revenue Growth
  • BOLD N/A
  • PXLW N/A
  • 52 Week Low
  • BOLD $1.00
  • PXLW $4.67
  • 52 Week High
  • BOLD $4.72
  • PXLW $15.03
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • PXLW 58.65
  • Support Level
  • BOLD N/A
  • PXLW $11.16
  • Resistance Level
  • BOLD N/A
  • PXLW $15.03
  • Average True Range (ATR)
  • BOLD 0.00
  • PXLW 1.36
  • MACD
  • BOLD 0.00
  • PXLW 0.13
  • Stochastic Oscillator
  • BOLD 0.00
  • PXLW 47.66

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: